Serum neurofilament light chain measurement can help identify individuals with radiologically isolated syndrome who are at high risk for multiple sclerosis conversion.
Disaster events disproportionally affect persons with disabilities; as there is an increasing likelihood of disasters globally, clinicians should consider identifying resources to prepare patients for disasters.
Nearly 25% of people with multiple sclerosis in our study reported wearing off prior to their next ocrelizumab infusion while on the standard 6-month dosing interval.